Carlsmed (CARL) Cash from Financing Activities (2024 - 2026)
Carlsmed's (CARL) quarterly Cash from Financing Activities came in at $243000.0 in Q2 2026, up 110.82% on a YoY basis from $115264.6 in Q2 2025, and down 44.27% quarter-over-quarter from $436000.0 in Q1 2026.
Powered by 
Analysis
Carlsmed (CARL) Cash from Financing Activities (2024 - 2026) Analysis & Trends
Carlsmed (CARL) has reported Cash from Financing Activities for 3 consecutive years, with $243000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Financing Activities rose 110.82% year-over-year to $243000.0; the trailing twelve-month figure through Jun 2026 stood at $91.4 million (up 291.62% YoY), and the FY2025 full-year result was $100.1 million, up 71.16% from the prior year.
- Cash from Financing Activities retreated to $243000.0 in Q2 2026 per CARL's latest filing, from $436000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $90.7 million in Q3 2025 and bottomed at -$2.2 million in Q2 2025.
- Historically, Cash from Financing Activities has averaged $14.3 million across 3 years, with a median of $339500.0 in 2026.
- The sharpest annual moves came in 2025 and 2026: Cash from Financing Activities jumped 551.41% in 2025, then tumbled 96.27% in 2026.
- Over 3 years, Cash from Financing Activities stood at -$51000.0 in 2024, then soared by 43.14% to -$29000.0 in 2025, then surged by 937.93% to $243000.0 in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $243000.0, $436000.0, and -$29000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | -263.16 Mn |
| 10 | Carlsmed | 424.72 Mn | 311.42 Mn | 14.54 Mn | 243,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 243,000.00 |
| Mar 31, 2026 | 436,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Sep 30, 2025 | 90.70 Mn |
| Jun 30, 2025 | -2.25 Mn |
| Mar 31, 2025 | 11.70 Mn |
| Dec 31, 2024 | -51,000.00 |
| Sep 30, 2024 | 13.92 Mn |